AllSight
CAH · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · 8-K · Item 1.01 · Aug 11, 2026

Cardinal replaces $4 billion of credit facilities with one longer-dated revolver

CARDINAL HEALTH INC (CAH) — AllSight decodes this SEC 8-K in plain English, versus what the market expected.

This is a refinancing and simplification, not new funding. Cardinal replaced a $2.0 billion five-year revolver, a $1.0 billion 364-day revolver, and a $1.0 billion receivables-sale program with a single unsecured $4.0 billion revolving facility. Total stated capacity is therefore unchanged, while the new facility runs through August 7, 2031. (Credit Agreement; Terminated Facilities)

FacilityCapacityStatus / maturity
New unsecured revolving facility$4.0 billionThrough August 7, 2031 (Credit Agreement)
Former five-year revolver$2.0 billionTerminated August 7, 2026 (Terminated Facilities)
Former 364-day revolver$1.0 billionTerminated August 7, 2026 (Terminated Facilities)
Receivables sale program$1.0 billionTerminated August 7, 2026 (Terminated Facilities)

The main change is longer-dated, more centralized liquidity. The filing extends the key maturity to 2031, permits up to two additional years of extensions subject to conditions, and removes the separate receivables-financing structure. That improves financing visibility and administrative simplicity, but the filing does not disclose a draw, a new borrowing need, or an increase in aggregate committed capacity. (Credit Agreement)

The credit terms look ordinary rather than signaling a new problem. The facility includes customary covenants and a maximum consolidated net leverage ratio of 4.00-to-1.00. Because the filing provides no updated leverage, pricing, utilization, or operating forecast, it does not establish a meaningful earnings or balance-sheet surprise versus expectations. The appropriate read is routine and broadly neutral: better maturity coverage, but no incremental liquidity or strategic change is disclosed. (Credit Agreement)

Read the original 8-K on SEC EDGAR ↗
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.